148 related articles for article (PubMed ID: 37965255)
21. Comparison of the replication and neutralization of different SARS-CoV-2 Omicron subvariants in vitro.
Zhang Y; Lv Q; Qi F; Li F; Deng R; Liang X; Liu M; Yan Y; Bao L
Animal Model Exp Med; 2023 Feb; 6(1):51-56. PubMed ID: 36808904
[TBL] [Abstract][Full Text] [Related]
22. Structural Basis for the Enhanced Infectivity and Immune Evasion of Omicron Subvariants.
Li Y; Shen Y; Zhang Y; Yan R
Viruses; 2023 Jun; 15(6):. PubMed ID: 37376697
[TBL] [Abstract][Full Text] [Related]
23. Raman Fingerprints of SARS-CoV-2 Omicron Subvariants: Molecular Roots of Virological Characteristics and Evolutionary Directions.
Pezzotti G; Ohgitani E; Fujita Y; Imamura H; Pappone F; Grillo A; Nakashio M; Shin-Ya M; Adachi T; Yamamoto T; Kanamura N; Marin E; Zhu W; Inaba T; Tanino Y; Nukui Y; Higasa K; Yasukochi Y; Okuma K; Mazda O
ACS Infect Dis; 2023 Nov; 9(11):2226-2251. PubMed ID: 37850869
[TBL] [Abstract][Full Text] [Related]
24. Immune Evasion of SARS-CoV-2 Omicron Subvariants.
Ke H; Chang MR; Marasco WA
Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146623
[TBL] [Abstract][Full Text] [Related]
25. Emerging Omicron subvariants evade neutralizing immunity elicited by vaccine or BA.1/BA.2 infection.
Chen Z; Li J; Zheng J; Jin Y; Zhang Y; Tang F; Li J; Cheng H; Jiang L; Wen H; Hong C; Zeng X; Huang S; Lu B; Li L; Wang Z
J Med Virol; 2023 Feb; 95(2):e28539. PubMed ID: 36719034
[TBL] [Abstract][Full Text] [Related]
26. Variable detection of Omicron-BA.1 and -BA.2 by SARS-CoV-2 rapid antigen tests.
Osterman A; Badell I; Dächert C; Schneider N; Kaufmann AY; Öztan GN; Huber M; Späth PM; Stern M; Autenrieth H; Muenchhoff M; Graf A; Krebs S; Blum H; Czibere L; Durner J; Kaderali L; Baldauf HM; Keppler OT
Med Microbiol Immunol; 2023 Feb; 212(1):13-23. PubMed ID: 36370197
[TBL] [Abstract][Full Text] [Related]
27. Epidemiological Insights into the Omicron Outbreak via MeltArray-Assisted Real-Time Tracking of SARS-CoV-2 Variants.
Yan T; Zheng R; Li Y; Sun S; Zeng X; Yue Z; Liao Y; Hu Q; Xu Y; Li Q
Viruses; 2023 Dec; 15(12):. PubMed ID: 38140638
[TBL] [Abstract][Full Text] [Related]
28. Neutralization of Omicron subvariants BA.1 and BA.5 by a booster dose of COVID-19 mRNA vaccine in a Japanese nursing home cohort.
Itamochi M; Yazawa S; Inasaki N; Saga Y; Yamazaki E; Shimada T; Tamura K; Maenishi E; Isobe J; Nakamura M; Takaoka M; Sasajima H; Kawashiri C; Tani H; Oishi K
Vaccine; 2023 Mar; 41(13):2234-2242. PubMed ID: 36858871
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of antiviral drugs against newly emerged SARS-CoV-2 Omicron subvariants.
Cho J; Shin Y; Yang JS; Kim JW; Kim KC; Lee JY
Antiviral Res; 2023 Jun; 214():105609. PubMed ID: 37086978
[TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 Omicron XBB subvariants exhibit enhanced fusogenicity and substantial immune evasion in elderly population, but high sensitivity to pan-coronavirus fusion inhibitors.
Xia S; Jiao F; Wang L; Yu X; Lu T; Fu Y; Huang Z; Li X; Huang J; Wang Q; Man Q; Xiong L; Jiang S; Lu L
J Med Virol; 2023 Mar; 95(3):e28641. PubMed ID: 36890632
[TBL] [Abstract][Full Text] [Related]
31. Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study.
Mok CKP; Chen C; Zhao S; Sun Y; Yiu K; Chan TO; Lai HL; Lai KC; Lau KM; Ling KC; Chan KKP; Ng SS; Ko FW; Peiris M; Hui DS
Lancet Microbe; 2023 Jun; 4(6):e418-e430. PubMed ID: 37086735
[TBL] [Abstract][Full Text] [Related]
32. Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants.
Wang XJ; Yao L; Zhang HY; Zhu KL; Zhao J; Zhan BD; Li YK; He XJ; Huang C; Wang ZY; Jiang MD; Yang P; Yang Y; Wang GL; Wang SQ; Dai EH; Gao HX; Ma MJ
Genome Med; 2022 Dec; 14(1):146. PubMed ID: 36581867
[TBL] [Abstract][Full Text] [Related]
33. Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower respiratory tract.
Hu B; Chan JF; Liu Y; Liu H; Chen YX; Shuai H; Hu YF; Hartnoll M; Chen L; Xia Y; Hu JC; Yuen TT; Yoon C; Hou Y; Huang X; Chai Y; Zhu T; Shi J; Wang Y; He Y; Cai JP; Zhou J; Yuan S; Zhang J; Huang JD; Yuen KY; To KK; Zhang BZ; Chu H
EBioMedicine; 2024 Jan; 99():104916. PubMed ID: 38101297
[TBL] [Abstract][Full Text] [Related]
34. Effects of a booster dose of BNT162b2 on spike-binding antibodies to SARS-CoV-2 Omicron BA.2, BA.3, BA.4 and BA.5 subvariants in infection-naïve and previously-infected individuals.
Kuzel TG; Fu J; Anderson M; Stec M; Boler M; Behun D; Gosha A; Cloherty G; Landay A; Moy J
Vaccine; 2023 Jan; 41(4):879-882. PubMed ID: 36572601
[TBL] [Abstract][Full Text] [Related]
35. Omicron (B.1.1.529) variant and its subvariants and lineages may lead to another COVID-19 wave in the world? -An overview of current evidence and counteracting strategies.
Sah R; Rais MA; Mohanty A; Chopra H; Chandran D; Bin Emran T; Dhama K
Int J Surg Open; 2023 Jun; 55():100625. PubMed ID: 37255735
[TBL] [Abstract][Full Text] [Related]
36. A spike-trimer protein-based tetravalent COVID-19 vaccine elicits enhanced breadth of neutralization against SARS-CoV-2 Omicron subvariants and other variants.
Wang R; Huang H; Yu C; Sun C; Ma J; Kong D; Lin Y; Zhao D; Zhou S; Lu J; Cao S; Zhang Y; Luo C; Li X; Wang Y; Xie L
Sci China Life Sci; 2023 Aug; 66(8):1818-1830. PubMed ID: 36598621
[TBL] [Abstract][Full Text] [Related]
37. Combined Use of RT-qPCR and NGS for Identification and Surveillance of SARS-CoV-2 Variants of Concern in Residual Clinical Laboratory Samples in Miami-Dade County, Florida.
Carattini YL; Griswold A; Williams S; Valiathan R; Zhou Y; Shukla B; Abbo LM; Parra K; Jorda M; Nimer SD; Sologon C; Gallegos HR; Weiss RE; Ferreira T; Memon A; Paige PG; Thomas E; Andrews DM
Viruses; 2023 Feb; 15(3):. PubMed ID: 36992302
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals.
Emmelot ME; Vos M; Boer MC; Rots NY; van Els CACM; Kaaijk P
Viruses; 2022 Dec; 15(1):. PubMed ID: 36680141
[TBL] [Abstract][Full Text] [Related]
39. Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events.
Ou J; Lan W; Wu X; Zhao T; Duan B; Yang P; Ren Y; Quan L; Zhao W; Seto D; Chodosh J; Luo Z; Wu J; Zhang Q
Signal Transduct Target Ther; 2022 Apr; 7(1):138. PubMed ID: 35474215
[TBL] [Abstract][Full Text] [Related]
40. The clinical characteristics of pediatric patients infected by SARS-CoV-2 Omicron variant and whole viral genome sequencing analysis.
Tsang HF; Yu ACS; Yim AKY; Jin N; Wu YO; Cheng HYL; Cheung WL; Leung WMS; Lam KW; Hung TN; Chan L; Chiou J; Pei XM; Lee OYA; Cho WCS; Wong SCC
PLoS One; 2023; 18(3):e0282389. PubMed ID: 36897843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
